Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30366356 | 0.81 | FAAH (0.44) | TBXAS1ALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL27164904 | 0.81 | NAPRT (0.53) | TBXAS1ALDH1A1NAPRTKDM4EMAPT | |
| SCHEMBL15763697 | 0.81 | ELANE (0.55) | ALDH1A1LMNAELANE | |
| SCHEMBL2011181 | 0.78 | LMNA (0.53) | TBXAS1ALDH1A1LMNAPOLBKDM4E | |
| SCHEMBL7824907 | 0.76 | ALDH1A1 (0.48) | TBXAS1ALDH1A1POLBNAPRTKDM4E | |
| SCHEMBL28328126 | 0.75 | P2RX7 (0.48) | P2RX7TBXAS1MYCALDH1A1POLB | |
| SCHEMBL10506862 | 0.74 | KMT2A (0.48) | ALDH1A1POLBKDM4EMAPTELANE | |
| SCHEMBL395689 | 0.74 | MAPT (0.44) | TBXAS1MAPTCYP24A1FAAHMGLL | |
| SCHEMBL16486800 | 0.74 | TBXAS1 (0.42) | TBXAS1ALDH1A1KDM4EMAPTCYP24A1 | |
| SCHEMBL31664989 | 0.74 | ALDH1A1 (0.50) | ALDH1A1POLBKDM4ETDP1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240052412-A1 | METHOD FOR DETECTING RNA STRUCTURE AT WHOLE TRANSCRIPTOME LEVEL AND USE THEREOF | TSINGHUA UNIVERSITY (CN) | 2024-02-15 | — | — | US | claimed |
| US-20230374566-A1 | METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-11-23 | — | — | US | claimed |
| EP-4217364-A1 | METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA | The Regents of the University of California (US) | 2023-08-02 | — | — | EP | claimed |
| US-20230079226-A1 | A METHOD OF DETERMINING A STRUCTURE OF RIBONUCLEIC ACID MOLECULES AND RELATED KITS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-03-16 | — | — | US | claimed |
| US-20220402883-A1 | COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION | ARRAKIS THERAPEUTICS, INC. | 2022-12-22 | — | — | US | claimed |
| EP-4103737-A1 | A METHOD OF DETERMINING A STRUCTURE OF RIBONUCLEIC ACID MOLECULES AND RELATED KITS | Agency for Science, Technology and Research (SG) | 2022-12-21 | — | — | EP | claimed |
| US-20220281860-A1 | COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES | ARRAKIS THERAPEUTICS, INC. | 2022-09-08 | — | — | US | claimed |
| US-20220267838-A1 | Sensitive and Accurate Genome-wide Profiling of RNA Structure In Vivo | THE PENN STATE RESEARCH FOUNDATION | 2022-08-25 | — | — | US | claimed |
| WO-2022094863-A1 | METHOD FOR DETECTING RNA STRUCTURE AT WHOLE TRANSCRIPTOME LEVEL AND USE THEREOF | 清华大学 | 2022-05-12 | — | — | WO | claimed |
| WO-2022067036-A1 | METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-03-31 | — | — | WO | claimed |
| WO-2021162637-A1 | A METHOD OF DETERMINING A STRUCTURE OF RIBONUCLEIC ACID MOLECULES AND RELATED KITS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-08-19 | — | — | WO | claimed |
| US-12503455-B2 | Nucleic acid-binding photoprobes and uses thereof | ARRAKIS THERAPEUTICS, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250154556-A1 | SINGLE-MOLECULE RNA STRUCTURE PROFILING | JOHN INNES CENTRE (GB) | 2025-05-15 | — | — | US | disclosed |
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | disclosed |
| EP-4482977-A1 | SINGLE-MOLECULE RNA STRUCTURE PROFILING | JOHN INNES CENTRE (GB) | 2025-01-01 | — | — | EP | disclosed |
| WO-2015021990-A1 | RNA PROBING METHOD AND REAGENTS | UNIVERSITY OF COPENHAGEN (DK) | 2015-02-19 | — | — | WO | disclosed |
| WO-2014110272-A1 | LOW SEQUENCE BIAS SINGLE-STRANDED DNA LIGATION | THE PENN STATE RESEARCH FOUNDATION (US) | 2014-07-17 | — | — | WO | disclosed |
| US-20140193860-A1 | Low Sequence Bias Single-Stranded DNA Ligation | THE PENN STATE RESEARCH FOUNDATION (US) | 2014-07-10 | — | — | US | disclosed |
| US-20080293712-A1 | Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof | WYETH (US) | 2008-11-27 | — | — | US | disclosed |
| WO-2008109613-A1 | BENZO[C][2,7]NAPHTHYRIDINE DERIVATIVES, AND THEIR USE AS KINASE INHIBITORS | WYETH (US) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | P2RX7 4442/4885TBXAS1 3335/4885MYC 987/4885 |
| US-20220281860-A1 | COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES | NSUN3, NSUN2, POLRMT | P2RX7 3210/4885TBXAS1 1574/4885MYC 547/4885 |
| US-12503455-B2 | Nucleic acid-binding photoprobes and uses thereof | NSUN3, NSUN2, TARBP1 | P2RX7 2442/4885TBXAS1 1011/4885MYC 1033/4885 |
| US-20220402883-A1 | COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION | NSUN3, NSUN2, METTL16 | P2RX7 2852/4885TBXAS1 2170/4885MYC 553/4885 |
| US-20080293712-A1 | Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof | PDPK1, PDK2, PDK3 | P2RX7 793/4885TBXAS1 826/4885MYC 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.